This inventor holds 2 USPTO granted patents. Top assignees: Chemisch Pharmazeutische Forschungsgesellschaft, Cl Pharma Aktiengesellschaft. Active years: 1989-1990.
Location History:
- Leitha, AT (1989)
- Bruck an der Leitha, AT (1990)
Company Filing History:
1 out of 1 
1 out of 11 Years Active: 1989-1990
Title: Franz Rovensky: Innovator in Pharmaceutical Chemistry
Introduction
Franz Rovensky is a notable inventor based in Bruck an der Leitha, Austria. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Rovensky's latest patents include a novel basic-substituted 5-halo-thienoisothiazol-3(2H)-one 1,1-dioxide. This invention relates to a compound characterized by the formula in which R₁ can denote hydrogen, (C₁-C₄)-alkyl, or halogen. Another significant patent is for novel 2-thienyloxyacetic acid derivatives, which are described by a general formula where R represents a phenyl or thienyl group. These compounds are potentially useful for treating thromboses, inflammations, high blood pressure, apoplexy, and angina pectoris.
Career Highlights
Throughout his career, Rovensky has worked with various organizations, including Chemisch Pharmazeutische Forschungsgesellschaft and Cl Pharma Aktiengesellschaft. His experience in these companies has contributed to his expertise in developing pharmaceutical innovations.
Collaborations
Rovensky has collaborated with notable colleagues such as Dieter Binder and Hubert P Ferber. These partnerships have likely enhanced his research and development efforts in the pharmaceutical sector.
Conclusion
Franz Rovensky is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to advancing medical treatments and improving patient outcomes.